Literature DB >> 3879192

Treatment for lateral epicondylitis: variables related to recovery.

S G Gerberich, J D Priest.   

Abstract

The purpose of this study was to determine the effectiveness of a treatment regime utilised for lateral epicondylitis that is designed to expedite return to activity and to identify variables related to treatment outcomes. Patients treated in a sports medicine clinic between 1978 and 1980 received, by mail, a brief questionnaire investigating the variables of the injuries and level of success of the treatment. Specific techniques ensured confidentiality and validation of information. Through the analyses conducted, an inverse relationship in the total group between the level of success and the duration of pain was documented; for example, the mean durations of pain, 17.3 months, 10.3 months, and 6.3 months correlated, respectively, with the levels of success, 0 (no recovery), 2 (moderate recovery), and 4 (complete recovery). In addition, the application of multiple risk factor analysis, incorporating a maximum of eight variables, identified the degree of pain prior to treatment as the most important predictor of complete recovery; the greater the pain the more likely the complete success of the treatments. The implications of these findings include a need for early case-finding to elicit the most favourable outcomes of the treatment regime studied.

Entities:  

Mesh:

Year:  1985        PMID: 3879192      PMCID: PMC1478390          DOI: 10.1136/bjsm.19.4.224

Source DB:  PubMed          Journal:  Br J Sports Med        ISSN: 0306-3674            Impact factor:   13.800


  10 in total

1.  Comparison of two steroid preparations used to treat tennis elbow, using the hypospray.

Authors:  A K Clarke; J Woodland
Journal:  Rheumatol Rehabil       Date:  1975-02

2.  ULTRASONIC MOVEMENT OF CORTISOL INTO PIG TISSUE. II. MOVEMENT INTO PARAVERTEBRAL NERVE.

Authors:  J E GRIFFIN; J C TOUCHSTONE; A C LIU
Journal:  Am J Phys Med       Date:  1965-02

3.  Ultrasonic movement of cortisol into pig tissues. I. Movement into skeletal muscle.

Authors:  J E GRIFFIN; J C TOUCHSTONE
Journal:  Am J Phys Med       Date:  1963-04

4.  Phonophoresis with 1 percent versus 10 percent hydrocortisone.

Authors:  J A Kleinkort; F Wood
Journal:  Phys Ther       Date:  1975-12

5.  Tennis elbow. The syndrome and a study of average players.

Authors:  J D Priest
Journal:  Minn Med       Date:  1976-06

6.  The etiology and treatment of tennis elbow.

Authors:  R P Nirschl
Journal:  J Sports Med       Date:  1974 Nov-Dec

7.  Patients treated with ultrasonic driven hydrocortisone and with ultrasound alone.

Authors:  J E Griffin; J L Echternach; R E Price; J C Touchstone
Journal:  Phys Ther       Date:  1967-07

8.  The treatment of tennis elbow with triamcinolone acetonide.

Authors:  A B Nevelös
Journal:  Curr Med Res Opin       Date:  1980       Impact factor: 2.580

9.  Tennis elbow. The surgical treatment of lateral epicondylitis.

Authors:  R P Nirschl; F A Pettrone
Journal:  J Bone Joint Surg Am       Date:  1979-09       Impact factor: 5.284

10.  Tennis elbow.

Authors:  H L Friedlander; R L Reid; R F Cape
Journal:  Clin Orthop Relat Res       Date:  1967 Mar-Apr       Impact factor: 4.176

  10 in total
  4 in total

Review 1.  A rational management of tennis elbow.

Authors:  M Kamien
Journal:  Sports Med       Date:  1990-03       Impact factor: 11.136

2.  Corticosteroid injections for lateral epicondylitis: a systematic overview.

Authors:  W J Assendelft; E M Hay; R Adshead; L M Bouter
Journal:  Br J Gen Pract       Date:  1996-04       Impact factor: 5.386

Review 3.  Epicondylar injury in sport: epidemiology, type, mechanisms, assessment, management and prevention.

Authors:  Patria A Hume; Duncan Reid; Tony Edwards
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

4.  Predictors for outcome in acute lateral epicondylitis.

Authors:  Øystein Holmedal; Morten Olaussen; Ibrahimu Mdala; Bård Natvig; Morten Lindbæk
Journal:  BMC Musculoskelet Disord       Date:  2019-08-17       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.